- Home
- AIXI vs RADX Comparison
AIXI vs RADX Comparison
Compare AIXI & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- RADX
- Stock Information
- Founded
- AIXI 2001
- RADX 2021
- Country
- AIXI China
- RADX Australia
- Employees
- AIXI N/A
- RADX N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- RADX
- Sector
- AIXI Technology
- RADX
- Exchange
- AIXI Nasdaq
- RADX NYSE
- Market Cap
- AIXI 31.2M
- RADX 32.5M
- IPO Year
- AIXI 2023
- RADX N/A
- Fundamental
- Price
- AIXI $2.54
- RADX $4.00
- Analyst Decision
- AIXI
- RADX Strong Buy
- Analyst Count
- AIXI 0
- RADX 2
- Target Price
- AIXI N/A
- RADX $13.50
- AVG Volume (30 Days)
- AIXI 119.3K
- RADX 23.0K
- Earning Date
- AIXI 05-15-2025
- RADX 02-26-2025
- Dividend Yield
- AIXI N/A
- RADX N/A
- EPS Growth
- AIXI N/A
- RADX N/A
- EPS
- AIXI N/A
- RADX N/A
- Revenue
- AIXI $70,314,315.00
- RADX $204,609.00
- Revenue This Year
- AIXI $26.84
- RADX N/A
- Revenue Next Year
- AIXI N/A
- RADX N/A
- P/E Ratio
- AIXI N/A
- RADX N/A
- Revenue Growth
- AIXI 18.84
- RADX N/A
- 52 Week Low
- AIXI $2.06
- RADX $3.50
- 52 Week High
- AIXI $8.31
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- AIXI 41.91
- RADX N/A
- Support Level
- AIXI $2.72
- RADX N/A
- Resistance Level
- AIXI $3.10
- RADX N/A
- Average True Range (ATR)
- AIXI 0.30
- RADX 0.00
- MACD
- AIXI 0.03
- RADX 0.00
- Stochastic Oscillator
- AIXI 34.12
- RADX 0.00
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.